AI Science Tracker
EN

Department of Ophthalmology, First Affiliated Hospital of Zhengzhou University, Henan Province Eye Hospital, Zhengzhou, China.

1 discovery from 2024

Discoveries

Identification of biomarkers associated with ferroptosis in diabetic retinopathy based on WGCNA and machine learning.

Source check: Source checked. Not independent scientific confirmation.

Finding: Integrated transcriptomics and ML select six ferroptosis-related diabetic-retinopathy markers; qPCR confirms expression and ROC analyses support diagnostic association. This is a specific clinically relevant biomarker result with experimental expression support. AI role: Weighted gene co-expression network analysis (WGCNA) and machine-learning feature selection. The article appeared in Frontiers In Genetics.

Technology: Weighted gene co-expression network analysis (WGCNA) and machine-learning feature selection

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

AI contribution
Weighted gene co-expression network analysis (WGCNA) and machine-learning feature selection
Test and result
Integrated transcriptomics and ML select six ferroptosis-related diabetic-retinopathy markers; qPCR confirms expression and ROC analyses support diagnostic association. This is a specific clinically relevant biomarker result with experimental expression support.
Limitation / still unknown
The result is limited to the described dataset, cohort, experimental system, or validation design; generalization beyond that scope and downstream real-world benefit are not established. Author affiliation was not stated in the reviewed abstract or metadata.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://www.frontiersin.org/journals/fgene/articles/10.3389/fgene.2024.1376771/full · https://pubmed.ncbi.nlm.nih.gov/38863444/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 3/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open the interactive profile for the timeline, or browse all organizations and model families.